Revvity Price to Book Ratio 2012-2026 | RVTY
Historical price to book ratio values for Revvity (RVTY) over the last 10 years. The current price to book ratio for Revvity as of September 16, 2026 is 2.16.
| Revvity Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2026-09-16 | 145.73 | 2.25 | |
| 2026-06-30 | 111.19 | $64.78 | 1.72 |
| 2026-03-31 | 87.49 | $64.34 | 1.36 |
| 2025-12-31 | 96.56 | $64.57 | 1.50 |
| 2025-09-30 | 87.41 | $64.68 | 1.35 |
| 2025-06-30 | 96.38 | $64.95 | 1.48 |
| 2025-03-31 | 105.35 | $63.96 | 1.65 |
| 2024-12-31 | 111.07 | $63.55 | 1.75 |
| 2024-09-30 | 127.06 | $64.88 | 1.96 |
| 2024-06-30 | 104.23 | $63.80 | 1.63 |
| 2024-03-31 | 104.29 | $63.54 | 1.64 |
| 2023-12-31 | 108.50 | $63.79 | 1.70 |
| 2023-09-30 | 109.81 | $62.38 | 1.76 |
| 2023-06-30 | 117.77 | $63.29 | 1.86 |
| 2023-03-31 | 132.04 | $63.77 | 2.07 |
| 2022-12-31 | 138.87 | $58.46 | 2.38 |
| 2022-09-30 | 119.10 | $55.98 | 2.13 |
| 2022-06-30 | 140.70 | $56.78 | 2.48 |
| 2022-03-31 | 172.52 | $56.97 | 3.03 |
| 2021-12-31 | 198.75 | $56.57 | 3.51 |
| 2021-09-30 | 171.23 | $55.14 | 3.11 |
| 2021-06-30 | 152.50 | $37.85 | 4.03 |
| 2021-03-31 | 126.64 | $35.71 | 3.55 |
| 2020-12-31 | 141.59 | $33.33 | 4.25 |
| 2020-09-30 | 123.77 | $28.89 | 4.28 |
| 2020-06-30 | 96.67 | $26.61 | 3.63 |
| 2020-03-31 | 74.12 | $24.79 | 2.99 |
| 2019-12-31 | 95.54 | $25.32 | 3.77 |
| 2019-09-30 | 83.73 | $24.37 | 3.44 |
| 2019-06-30 | 94.64 | $24.37 | 3.88 |
| 2019-03-31 | 94.59 | $23.79 | 3.98 |
| 2018-12-31 | 77.04 | $23.37 | 3.30 |
| 2018-09-30 | 95.33 | $23.16 | 4.12 |
| 2018-06-30 | 71.70 | $22.74 | 3.15 |
| 2018-03-31 | 74.07 | $23.10 | 3.21 |
| 2017-12-31 | 71.47 | $22.68 | 3.15 |
| 2017-09-30 | 67.34 | $23.01 | 2.93 |
| 2017-06-30 | 66.47 | $22.13 | 3.00 |
| 2017-03-31 | 56.56 | $20.11 | 2.81 |
| 2016-12-31 | 50.74 | $19.65 | 2.58 |
| 2016-09-30 | 54.52 | $19.50 | 2.80 |
| 2016-06-30 | 50.87 | $19.09 | 2.66 |
| 2016-03-31 | 47.93 | $18.80 | 2.55 |
| 2015-12-31 | 51.84 | $18.84 | 2.75 |
| 2015-09-30 | 44.41 | $18.36 | 2.42 |
| 2015-06-30 | 50.80 | $18.71 | 2.71 |
| 2015-03-31 | 49.28 | $18.20 | 2.71 |
| 2014-12-31 | 42.07 | $18.16 | 2.32 |
| 2014-09-30 | 41.88 | $18.26 | 2.29 |
| 2014-06-30 | 44.92 | $18.21 | 2.47 |
| 2014-03-31 | 43.14 | $17.94 | 2.40 |
| 2013-12-31 | 39.41 | $17.71 | 2.23 |
| 2013-09-30 | 36.02 | $17.08 | 2.11 |
| 2013-06-30 | 30.94 | $16.61 | 1.86 |
| 2013-03-31 | 31.96 | $16.40 | 1.95 |
| 2012-12-31 | 30.10 | $16.86 | 1.78 |
| 2012-09-30 | 27.88 | $16.95 | 1.64 |
| 2012-06-30 | 24.34 | $16.53 | 1.47 |
| 2012-03-31 | 26.02 | $16.54 | 1.57 |
| 2011-12-31 | 18.76 | $16.28 | 1.15 |
| 2011-09-30 | 17.95 | $17.20 | 1.04 |
| 2011-06-30 | 25.08 | $17.30 | 1.45 |
| 2011-03-31 | 24.42 | $16.93 | 1.44 |
| 2010-12-31 | 23.94 | $16.64 | 1.44 |
| 2010-09-30 | 21.38 | $14.46 | 1.48 |
| 2010-06-30 | 19.03 | $13.94 | 1.37 |
| 2010-03-31 | 21.94 | $13.85 | 1.58 |
| 2009-12-31 | 18.84 | $13.92 | 1.35 |
| 2009-09-30 | 17.55 | $13.72 | 1.28 |
| 2009-06-30 | 15.80 | $13.49 | 1.17 |
| 2009-03-31 | 11.54 | $12.99 | 0.89 |
| 2008-12-31 | 12.51 | $13.39 | 0.93 |
| 2008-09-30 | 22.38 | $13.85 | 1.62 |
| 2008-06-30 | 24.90 | $13.94 | 1.79 |
| 2008-03-31 | 21.62 | $13.73 | 1.57 |
| 2007-12-31 | 23.13 | $13.40 | 1.73 |
| 2007-09-30 | 25.90 | $12.97 | 2.00 |
| 2007-06-30 | 23.05 | $12.65 | 1.82 |
| 2007-03-31 | 21.36 | $12.71 | 1.68 |
| 2006-12-31 | 19.55 | $12.80 | 1.53 |
| 2006-09-30 | 16.59 | $12.66 | 1.31 |
| 2006-06-30 | 18.25 | $12.63 | 1.45 |
| 2006-03-31 | 20.43 | $12.46 | 1.64 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $15.643B | $2.856B |
| Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $147.177B | 25.78 |
| CVS Health (CVS) | United States | $120.850B | 12.05 |
| HCA Healthcare (HCA) | United States | $91.758B | 14.27 |
| Elevance Health (ELV) | United States | $90.552B | 14.21 |
| Cencora (COR) | United States | $61.693B | 18.85 |
| Natera (NTRA) | United States | $50.563B | 0.00 |
| Labcorp Holdings (LH) | United States | $26.274B | 18.52 |
| Viatris (VTRS) | United States | $19.124B | 6.61 |
| Medpace Holdings (MEDP) | United States | $17.319B | 36.37 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $16.369B | 0.00 |
| DiDi Global (DIDIY) | China | $16.046B | 176.00 |
| Solventum (SOLV) | United States | $15.330B | 12.69 |
| ICON (ICLR) | Ireland | $13.204B | 17.94 |
| Charles River Laboratories (CRL) | United States | $13.027B | 27.56 |
| BrightSpring Health Services (BTSG) | United States | $11.642B | 40.03 |
| Avantor (AVTR) | United States | $10.443B | 18.83 |
| BioMerieux (BMXMF) | France | $10.192B | 0.00 |
| Caris Life Sciences,�Inc (CAI) | United States | $8.054B | 79.17 |
| HealthEquity (HQY) | United States | $7.983B | 26.01 |
| Sonic Healthcare (SKHHY) | Australia | $6.771B | 0.00 |
| PACS (PACS) | United States | $6.662B | 22.39 |
| GETINGE (GNGBY) | Sweden | $6.654B | 18.79 |
| CochLear (CHEOY) | Australia | $6.327B | 0.00 |
| MiniMed (MMED) | United States | $6.193B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $6.157B | 23.28 |
| Sotera Health (SHC) | United States | $5.416B | 22.33 |
| Concentras Parent (CON) | United States | $4.542B | 22.40 |
| Organon (OGN) | United States | $3.587B | 4.55 |
| GeneDx Holdings (WGS) | United States | $2.822B | 262.89 |
| CareDx (CDNA) | United States | $2.723B | 309.65 |
| Amplifon S.p.A (AMFPF) | Italy | $2.466B | 12.74 |
| Pediatrix Medical (MD) | United States | $2.169B | 12.71 |
| Alignment Healthcare (ALHC) | United States | $2.151B | 54.58 |
| Establishment Labs Holdings (ESTA) | United States | $2.130B | 0.00 |
| Progyny (PGNY) | United States | $2.130B | 30.17 |
| COMPASS Pathways (CMPS) | United Kingdom | $1.912B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $1.907B | 0.00 |
| Surgery Partners (SGRY) | United States | $1.787B | 68.25 |
| Bora Pharmaceuticals, - (BORAY) | Taiwan | $1.695B | 10.18 |
| Freenome (FRNM) | United States | $1.573B | 0.00 |
| Agilon Health (AGL) | United States | $1.547B | 0.00 |
| Ardent Health (ARDT) | United States | $1.508B | 8.62 |
| InnovAge Holding (INNV) | United States | $1.490B | 0.00 |
| Nutex Health (NUTX) | United States | $1.475B | 8.45 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.241B | 0.00 |
| Omada Health (OMDA) | United States | $1.204B | 245.88 |
| GoodRx Holdings (GDRX) | United States | $1.196B | 23.27 |
| Teladoc Health (TDOC) | United States | $1.195B | 0.00 |
| CryoPort (CYRX) | United States | $0.826B | 0.00 |
| Enhabit (EHAB) | United States | $0.709B | 25.89 |
| GMR Solutions (GMRS) | United States | $0.688B | 0.00 |
| Oncology Institute (TOI) | United States | $0.507B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.504B | 0.00 |
| SBC Medicals (SBC) | United States | $0.472B | 9.77 |
| Strata Critical Medical (SRTA) | United States | $0.468B | 0.00 |
| Forward Industries (FWDI) | United States | $0.449B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.382B | 5.55 |
| Shoulder Innovations (SI) | United States | $0.374B | 0.00 |
| Biodesix (BDSX) | United States | $0.292B | 0.00 |
| Embecta (EMBC) | United States | $0.288B | 2.50 |
| So-Young (SY) | China | $0.276B | 0.00 |
| LifeMD (LFMD) | United States | $0.164B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.107B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.098B | 0.00 |
| SkinHealth Systems (SKIN) | United States | $0.088B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.079B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.068B | 8.06 |
| Tevogen (TVGN) | United States | $0.050B | 0.00 |
| DocGo (DCGO) | United States | $0.038B | 0.00 |
| Lifeward (LFWD) | United States | $0.020B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.013B | 0.00 |
| Ainos (AIMD) | United States | $0.010B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.008B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| Aclarion (ACON) | United States | $0.008B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.007B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| 20/20 Biolabs (AIDX) | United States | $0.006B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| Pomdoctor - (POM) | China | $0.006B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.004B | 0.00 | |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |